Patient P-02667

Synthetic patientMETA-24 · Day 114 · 25–34 · M · baseline S08Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S08
Day 76 HY-01 recommended — Hydration Protocol HY-01
Day 77 Patient accepted — Started HY-01 in the companion
Day 81 GI symptom burden −18% vs expected — Hydration Protocol HY-01
Day 87 Tolerance state changed — Unstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity-8
Treatment adherence+5

What helped?

Hydration Protocol HY-01Day 76
Result: symptom burden −18%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

62 min

worsening · -7.3 vs previous 14 d

Sleep duration

Wearable

7.4 h

stable · -0.0 vs previous 14 d

Energy level

Daily log

7/10

worsening · -0.4 vs previous 14 d

Steps

Wearable

7,601

worsening · -570 vs previous 14 d

GI burden

Companion

20.1/100

worsening · +10.6 vs previous 14 d

Adherence

Companion

100 %

stable · +2.5 vs previous 14 d

Sleep quality

Wearable

55/100

worsening · -4.7 vs previous 14 d

Glucose, CGM daily mean

CGM

121 mg/dL

stable · +3.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 85 from the failing basin, 3 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.5 next day on high-intake days · n 23

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-5.5supporter · 95%
Alcohol
+1.1no signal · 23%
Caffeine
-0.8no signal · 15%
Ultra-processed food
-0.7no signal · 15%
Dietary fat load
-0.4no signal · 15%
Histamine load
-0.4no signal · 15%
Simple carbohydrates
-0.3no signal · 15%
Insoluble fibre
+0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 37 ms, trending down
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.7 · butyrate capacity 75/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 38 ms
Sleep: 7.4 h
Steps: 6,498
Resting HR: 74 bpm

Daily log: GI score 20, nutritional resilience 66, adherence 100.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02630	52%	S17	NP-02	improved	76
P-02415	49%	S17	GI-04	improved	86
P-02690	44%	S02	ME-01	improved	73
P-02450	41%	S12	NP-02	improved	92
P-02486	41%	S10	ME-01	improved	86
P-02277	39%	S05	AD-05	improved	92
P-02127	38%	S11	SC-12	improved	73
P-02464	38%	S18	ME-01	improved	68
P-02193	36%	S11	CR-01	improved	87
P-02068	35%	S14	NP-02	improved	83
P-02249	34%	S09	DT-01	improved	100
P-02354	34%	S01	CR-01	improved	78